Correlation Between Atea Pharmaceuticals and Unity Biotechnology
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Unity Biotechnology, you can compare the effects of market volatilities on Atea Pharmaceuticals and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Unity Biotechnology.
Diversification Opportunities for Atea Pharmaceuticals and Unity Biotechnology
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Atea and Unity is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Unity Biotechnology go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Unity Biotechnology
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Unity Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 6.15 times less risky than Unity Biotechnology. The stock trades about -0.26 of its potential returns per unit of risk. The Unity Biotechnology is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 114.00 in Unity Biotechnology on November 3, 2024 and sell it today you would earn a total of 108.00 from holding Unity Biotechnology or generate 94.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Unity Biotechnology
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Unity Biotechnology |
Atea Pharmaceuticals and Unity Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Unity Biotechnology
The main advantage of trading using opposite Atea Pharmaceuticals and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |